CTLA4 and rheumatoid arthritis: In humans, genetic polymorphisms of forkhead box P3 (FOXP3), a master regulator of Tregs and cytotoxic T-lymphocyte associated protein 4 (CTLA4), one of the main co-inhibitory molecules in Tregs, are linked to RA risk [6, 7].